Metabolism and Target Organ Damage is Accepted for Inclusion in Scopus
We are thrilled to share some exciting news with all! Metabolism and Target Organ Damage (M&TOD) has been officially accepted for inclusion in Scopus, the world's largest abstract and citation database of peer-reviewed literature. This significant achievement stands as a testament to the unwavering commitment and dedication demonstrated by our esteemed editorial team, authors, and reviewers.
M&TOD was launched in 2021, and it is an international, peer-reviewed, open-access interdisciplinary journal that provides an online platform for the publication of clinical, basic, and translational studies, covering (cardio)-metabolic disorders per se, such as obesity, diabetes, dyslipidemias, arterial hypertension, and hyperuricemia in all age groups.
As we move forward, we remain dedicated to promoting cutting-edge research and facilitating meaningful collaborations within the scientific community. With Scopus's recognition, we are poised to expand our reach and impact, and we hope to continue making meaningful contributions to the scientific landscape.
Scopus, as the largest abstract and citation database, encompasses a wide range of scientific journals, books, and conference proceedings. It provides a comprehensive overview of research output in diverse fields, including science, technology, medicine, social sciences, arts, and humanities. Scopus's smart tools empower researchers to track, analyze, and visualize research trends, fostering advancements across various domains.